NEW YORK STOCK EXCHANGE, INC. · DNA
-0.25% · -$0.0200 · Vol 697.2K
Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc

Life Sciences Tools & Services
$7.98

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is DNA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Ginkgo Bioworks Holdings Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Founded
Listed
2021
Employees
485
HQ
US

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$8.00
Day high
$8.20
Day low
$7.76
Previous close
$8.00
52W high
$8.20
-2.68% from high
52W low
$7.70
56% of range
Market cap
$515.4M
P/E
EPS
Dividend yield
Beta
Shares out
65.3M
Float
Volume
697.2K
Avg volume
VWAP
$7.92
Next earnings
Price history computed in-house
1W
+0.63%
1M
+0.63%
3M
+0.63%
1Y
+0.63%
YTD
+0.63%
SMA 50 $7.87 · above
SMA 200 $7.87 · above
52W position 56%
Veridion warehouse edge

Warehouse intelligence for DNA.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

DNA insider activity

Ginkgo Bioworks Holdings Inc

Score
Coverage building
Pressure
Net selling
Filings
20
Buys / sells
0 / 20
Net value
-$3.9M
Insiders
5
Named filers
CP
Coen Steven P.
Insider
Leadership
CB
Canton Barry
Insider
Leadership
SP
Shetty Reshma P.
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$3.9M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-262026-05-22Coen Steven P.Insidersell$8.3330750,704$3KSEC Form 4
2026-04-202026-04-17Coen Steven P.Insidersell$7.9532450,268$3KSEC Form 4
2026-04-142026-04-13Coen Steven P.Insidersell$6.4133,17149,849$213KSEC Form 4
2026-04-132026-04-10Canton BarryInsidersell$6.43124,727436,422$802KSEC Form 4
2026-04-132026-04-10Shetty Reshma P.Insidersell$6.43124,727436,422$802KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 15 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

DNA contract awards, year to date.

Public federal awards linked to this ticker.

$3.2M
Refresh interval: 12hSource: Federal contract awards
Department of Health and Human Services
$3.2M
METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS)

METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS)

May 19, 2026
Lobbying spend

DNA lobbying filings, year to date.

Registered lobbying filings matched to Ginkgo Bioworks Holdings Inc.

$210.0K
Refresh interval: 12hSource: LDA disclosure filings
Budget/Appropriations Defense Medical/Disease Research/Clinical LabsMedical/Disease Research/Clinical Labs
Filing
$60.0K
GINKGO BIOWORKS INC.

CROSSROADS STRATEGIES, LLC

Apr 20, 2026
Filing
$60.0K
GINKGO BIOWORKS INC.

CORNERSTONE GOVERNMENT AFFAIRS, INC.

Apr 15, 2026
Filing
$60.0K
GINKGO BIOWORKS INC.

CORNERSTONE GOVERNMENT AFFAIRS, INC.

Jan 16, 2026
Latest news · DNA
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for DNA.
Options
Sovereign unlock shows live options positioning for DNA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.